bpc-157 case report adverse event human BPC-157: Everyone's Sure It Works, but the Evidence Is Empty FDA Committee Votes to Ease

Glycoaminoglycan (GAG) deficiency in protective barrier as an underlying, primary cause of ulcerative colitis, Crohn's disease interstitial cystitis and possibly Reiter's syndrome

A review in Current Sports Medicine Reports warned of the widespread use of peptides from non-clinical suppliers, highlighting the lack of sterility and the high incidence of batch inconsistencies (1)

However, systematic reviews and randomised controlled trials supporting these claims are notably absent from peer-reviewed literature

It is not a prescribed medicine

Rather than acting through a single well-defined receptor, DSIP appears to influence multiple signaling systems, including stress-response and sleep-regulatory networks